Is tenofovir monotherapy a sufficient defense line against multi-drug resistant hepatitis B virus?
作者信息
Lee Yun Bin, Lee Jeong-Hoon
机构信息
Department of Internal Medicine, CHA Bundang Medical Center, CHA University, Seongnam, Korea.
Department of Internal Medicine and Liver Research Institute, Seoul National University College of Medicine, Seoul, Korea.
出版信息
Clin Mol Hepatol. 2017 Sep;23(3):219-221. doi: 10.3350/cmh.2017.0045. Epub 2017 Sep 19.
Abstract
摘要
相似文献
1
Is tenofovir monotherapy a sufficient defense line against multi-drug resistant hepatitis B virus?
Clin Mol Hepatol. 2017 Sep;23(3):219-221. doi: 10.3350/cmh.2017.0045. Epub 2017 Sep 19.
2
Selection of an entecavir-resistant mutant despite prolonged hepatitis B virus DNA suppression, in a chronic hepatitis B patient with preexistent lamivudine resistance: successful rescue therapy with tenofovir.
Eur J Gastroenterol Hepatol. 2008 Aug;20(8):773-7. doi: 10.1097/MEG.0b013e3282f793d6.
3
Efficacy of tenofovir-based rescue therapy for chronic hepatitis B patients with resistance to lamivudine and entecavir.
Clin Mol Hepatol. 2017 Sep;23(3):230-238. doi: 10.3350/cmh.2017.0003. Epub 2017 Jun 30.
4
Tenofovir versus tenofovir plus entecavir for chronic hepatitis B with lamivudine resistance and entecavir resistance.
J Viral Hepat. 2017 Feb;24(2):141-147. doi: 10.1111/jvh.12623. Epub 2016 Oct 20.
5
Antiviral effect of entecavir in chronic hepatitis B: influence of prior exposure to nucleos(t)ide analogues.
J Hepatol. 2010 Apr;52(4):493-500. doi: 10.1016/j.jhep.2010.01.012. Epub 2010 Feb 4.
6
Long-term efficacy and safety of lamivudine, entecavir, and tenofovir for treatment of hepatitis B virus-related cirrhosis.
Clin Gastroenterol Hepatol. 2013 Jan;11(1):88-94. doi: 10.1016/j.cgh.2012.10.003. Epub 2012 Oct 9.
7
Entecavir plus tenofovir versus entecavir plus adefovir in chronic hepatitis B patients with a suboptimal response to lamivudine and adefovir combination therapy.
Clin Mol Hepatol. 2015 Sep;21(3):242-8. doi: 10.3350/cmh.2015.21.3.242. Epub 2015 Sep 30.
8
Tenofovir-based rescue therapy for chronic hepatitis B patients who had failed treatment with lamivudine, adefovir, and entecavir.
J Gastroenterol Hepatol. 2015 Oct;30(10):1514-21. doi: 10.1111/jgh.12993.
9
Tenofovir rescue regimen following prior suboptimal response to entecavir and adefovir combination therapy in chronic hepatitis B patients exposed to multiple treatment failures.
J Med Virol. 2015 Jun;87(6):1013-21. doi: 10.1002/jmv.24153. Epub 2015 Feb 25.
10
Dynamics of hepatitis B virus resistance substitutions correlates with virological response in lamivudine-refractory patients with entecavir rescue monotherapy.
Virus Res. 2013 Nov 6;177(2):156-62. doi: 10.1016/j.virusres.2013.08.003. Epub 2013 Aug 19.
引用本文的文献
1
Hepatitis B virus resistance to tenofovir: fact or fiction? A systematic literature review and structural analysis of drug resistance mechanisms.
Wellcome Open Res. 2020 Jun 29;5:151. doi: 10.12688/wellcomeopenres.15992.1. eCollection 2020.
2
Entecavir+tenofovir vs. lamivudine/telbivudine+adefovir in chronic hepatitis B patients with prior suboptimal response.
Clin Mol Hepatol. 2020 Jul;26(3):352-363. doi: 10.3350/cmh.2019.0044n. Epub 2020 May 28.
本文引用的文献
1
Efficacy of tenofovir-based rescue therapy for chronic hepatitis B patients with resistance to lamivudine and entecavir.
Clin Mol Hepatol. 2017 Sep;23(3):230-238. doi: 10.3350/cmh.2017.0003. Epub 2017 Jun 30.
2
EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection.
J Hepatol. 2017 Aug;67(2):370-398. doi: 10.1016/j.jhep.2017.03.021. Epub 2017 Apr 18.
3
Monotherapy with tenofovir disoproxil fumarate for multiple drug-resistant chronic hepatitis B: 3-year trial.
Hepatology. 2017 Sep;66(3):772-783. doi: 10.1002/hep.29187. Epub 2017 Jul 18.
4
Tenofovir has inferior efficacy in adefovir-experienced chronic hepatitis B patients compared to nucleos(t)ide-naïve patients.
Clin Mol Hepatol. 2017 Mar;23(1):66-73. doi: 10.3350/cmh.2016.0060. Epub 2017 Feb 14.
5
AASLD guidelines for treatment of chronic hepatitis B.
Hepatology. 2016 Jan;63(1):261-83. doi: 10.1002/hep.28156. Epub 2015 Nov 13.
6
Tenofovir monotherapy versus tenofovir and entecavir combination therapy in patients with entecavir-resistant chronic hepatitis B with multiple drug failure: results of a randomised trial.
Gut. 2016 May;65(5):852-60. doi: 10.1136/gutjnl-2014-308353. Epub 2015 Jan 16.
7
Tenofovir monotherapy versus tenofovir plus lamivudine or telbivudine combination therapy in treatment of lamivudine-resistant chronic hepatitis B.
Antimicrob Agents Chemother. 2015 Feb;59(2):972-8. doi: 10.1128/AAC.04454-14. Epub 2014 Nov 24.
8
Efficacy of entecavir-tenofovir combination therapy for chronic hepatitis B patients with multidrug-resistant strains.
Antimicrob Agents Chemother. 2014 Nov;58(11):6710-6. doi: 10.1128/AAC.03845-14. Epub 2014 Aug 25.
Zotero 插件